IBC Addresses Critical Supply Shortages of Ac-225 with Commercially Available Molecular Recognition Technology™ (MRT™) for Highly Selective Separation of Ac-225
- Written by PR Newswire
![]() |
- Strong clinical potential of radioligand therapy is evident from recently published clinical trial results
- Global supply shortage of Ac-225 is impacting supply to clinical trials
- Demand is increasing for high-purity isotopes to conduct and scale up clinical studies and support regulatory approvals in the US and Europe
- IBC's state-of-the-art...















